In this study, soluble HLA-G levels in DM2 patients were measured, finding increased levels of this molecule; those who were soluble HLA-G positive had higher body mass index, systolic blood pressure, and cholesterol levels. The gene discussed is HLA-G; the disease is myotonic dystrophy type 2.